TA
Tatli, Ali Murat
3 yayın · 17 atıf · 2022–2023
Yayın
3
Atıf
17
Yıllar
2
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group
|
2023 | Article | 8 |
|
Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically
|
2023 | Article | 0 |
|
Lung Cancer in Turkey
|
2022 | Editorial Material | 9 |